Rockwell Net Debt vs Deferred Long Term Liab Analysis

RMTI Stock

USD 2.20 0.13 5.58%

Rockwell Medical financial indicator trend analysis is much more than just breaking down Rockwell Medical prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Rockwell Medical is a good investment. Please check the relationship between Rockwell Medical Net Debt and its Deferred Long Term Liab accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rockwell Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more detail on how to invest in Rockwell Stock please use our How to Invest in Rockwell Medical guide.

Net Debt vs Deferred Long Term Liab

Net Debt vs Deferred Long Term Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Rockwell Medical Net Debt account and Deferred Long Term Liab. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Rockwell Medical's Net Debt and Deferred Long Term Liab is -0.4. Overlapping area represents the amount of variation of Net Debt that can explain the historical movement of Deferred Long Term Liab in the same time period over historical financial statements of Rockwell Medical, assuming nothing else is changed. The correlation between historical values of Rockwell Medical's Net Debt and Deferred Long Term Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Debt of Rockwell Medical are associated (or correlated) with its Deferred Long Term Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Deferred Long Term Liab has no effect on the direction of Net Debt i.e., Rockwell Medical's Net Debt and Deferred Long Term Liab go up and down completely randomly.

Correlation Coefficient

-0.4

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.

Deferred Long Term Liab

Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.

Most indicators from Rockwell Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Rockwell Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rockwell Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more detail on how to invest in Rockwell Stock please use our How to Invest in Rockwell Medical guide.As of now, Rockwell Medical's Enterprise Value is decreasing as compared to previous years.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	27.9M	20.9M	15.4M	19.7M
Cost Of Revenue	64.4M	68.7M	74.9M	41.4M

Total Operating Expenses Cost Of Revenue

Rockwell Medical fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Common Stock	Intangible Assets	Common Stock Total Equity	Other Assets
Total Assets		0.11	-0.11	-0.21	0.91	-0.08	-0.73	-0.32	-0.17	0.8	-0.09	0.02	0.94	0.18	0.03	0.66	0.2	-0.06	0.49	-0.14	0.98	0.55	0.54	-0.04	0.53	-0.05
Short Long Term Debt Total	0.11		0.33	0.36	-0.23	0.64	0.37	-0.65	-0.13	0.17	0.45	-0.03	-0.02	0.28	0.41	-0.04	0.34	0.66	0.75	0.56	0.02	0.31	-0.43	0.73	-0.44	0.35
Other Current Liab	-0.11	0.33		0.59	-0.29	0.53	0.29	-0.47	0.54	-0.09	0.56	-0.28	-0.27	0.53	0.59	0.07	-0.03	0.47	0.36	0.55	-0.18	-0.16	-0.33	0.51	-0.34	0.56
Total Current Liabilities	-0.21	0.36	0.59		-0.52	0.28	0.34	-0.25	0.73	-0.16	0.14	-0.22	-0.3	0.19	0.07	-0.11	0.31	0.24	0.57	0.27	-0.27	0.03	-0.22	0.23	-0.24	0.07
Total Stockholder Equity	0.91	-0.23	-0.29	-0.52		-0.25	-0.82	-0.08	-0.3	0.72	-0.18	0.02	0.9	0.1	-0.03	0.61	-0.02	-0.24	0.09	-0.27	0.93	0.39	0.61	-0.23	0.61	-0.09
Property Plant And Equipment Net	-0.08	0.64	0.53	0.28	-0.25		0.47	-0.84	-0.26	-0.1	0.91	-0.13	-0.34	0.7	0.87	-0.01	0.32	0.94	0.34	0.97	-0.23	0.14	-0.64	0.91	-0.65	0.79
Net Debt	-0.73	0.37	0.29	0.34	-0.82	0.47		-0.17	0.04	-0.85	0.46	0.15	-0.85	0.21	0.31	-0.2	0.13	0.39	-0.02	0.5	-0.79	-0.17	-0.57	0.38	-0.57	0.33
Retained Earnings	-0.32	-0.65	-0.47	-0.25	-0.08	-0.84	-0.17		0.26	-0.19	-0.73	-0.01	-0.05	-0.71	-0.74	-0.32	-0.52	-0.81	-0.61	-0.76	-0.18	-0.4	0.28	-0.75	0.29	-0.68
Accounts Payable	-0.17	-0.13	0.54	0.73	-0.3	-0.26	0.04	0.26		-0.11	-0.21	-0.23	-0.12	0.0	-0.2	-0.05	-0.11	-0.31	0.21	-0.22	-0.13	-0.25	0.17	-0.23	0.16	-0.19
Cash	0.8	0.17	-0.09	-0.16	0.72	-0.1	-0.85	-0.19	-0.11		-0.2	-0.23	0.86	-0.06	-0.07	0.13	0.03	-0.01	0.41	-0.19	0.82	0.29	0.3	0.04	0.29	-0.12
Non Current Assets Total	-0.09	0.45	0.56	0.14	-0.18	0.91	0.46	-0.73	-0.21	-0.2		0.0	-0.38	0.85	0.96	0.07	0.11	0.79	0.15	0.91	-0.24	0.02	-0.48	0.82	-0.49	0.89
Non Currrent Assets Other	0.02	-0.03	-0.28	-0.22	0.02	-0.13	0.15	-0.01	-0.23	-0.23	0.0		-0.04	0.0	-0.17	0.3	0.23	-0.19	0.0	-0.14	-0.01	0.29	0.31	-0.14	0.31	0.05
Cash And Short Term Investments	0.94	-0.02	-0.27	-0.3	0.9	-0.34	-0.85	-0.05	-0.12	0.86	-0.38	-0.04		-0.11	-0.25	0.49	0.09	-0.28	0.36	-0.4	0.98	0.46	0.6	-0.26	0.6	-0.32
Net Receivables	0.18	0.28	0.53	0.19	0.1	0.7	0.21	-0.71	0.0	-0.06	0.85	0.0	-0.11		0.88	0.37	0.09	0.5	0.23	0.73	0.06	0.2	-0.01	0.57	-0.03	0.8
Common Stock Shares Outstanding	0.03	0.41	0.59	0.07	-0.03	0.87	0.31	-0.74	-0.2	-0.07	0.96	-0.17	-0.25	0.88		0.13	0.0	0.75	0.14	0.88	-0.11	0.0	-0.41	0.8	-0.42	0.89
Inventory	0.66	-0.04	0.07	-0.11	0.61	-0.01	-0.2	-0.32	-0.05	0.13	0.07	0.3	0.49	0.37	0.13		0.24	-0.08	0.31	0.02	0.61	0.51	0.51	-0.05	0.51	0.16
Other Current Assets	0.2	0.34	-0.03	0.31	-0.02	0.32	0.13	-0.52	-0.11	0.03	0.11	0.23	0.09	0.09	0.0	0.24		0.44	0.53	0.15	0.14	0.32	-0.17	0.2	-0.18	-0.04
Other Stockholder Equity	-0.06	0.66	0.47	0.24	-0.24	0.94	0.39	-0.81	-0.31	-0.01	0.79	-0.19	-0.28	0.5	0.75	-0.08	0.44		0.35	0.85	-0.19	-0.02	-0.77	0.9	-0.78	0.71
Total Liab	0.49	0.75	0.36	0.57	0.09	0.34	-0.02	-0.61	0.21	0.41	0.15	0.0	0.36	0.23	0.14	0.31	0.53	0.35		0.23	0.41	0.51	0.01	0.38	0.0	0.07
Property Plant And Equipment Gross	-0.14	0.56	0.55	0.27	-0.27	0.97	0.5	-0.76	-0.22	-0.19	0.91	-0.14	-0.4	0.73	0.88	0.02	0.15	0.85	0.23		-0.28	0.17	-0.58	0.87	-0.59	0.82
Total Current Assets	0.98	0.02	-0.18	-0.27	0.93	-0.23	-0.79	-0.18	-0.13	0.82	-0.24	-0.01	0.98	0.06	-0.11	0.61	0.14	-0.19	0.41	-0.28		0.51	0.61	-0.17	0.6	-0.18
Short Term Debt	0.55	0.31	-0.16	0.03	0.39	0.14	-0.17	-0.4	-0.25	0.29	0.02	0.29	0.46	0.2	0.0	0.51	0.32	-0.02	0.51	0.17	0.51		0.43	0.03	0.43	-0.09
Common Stock	0.54	-0.43	-0.33	-0.22	0.61	-0.64	-0.57	0.28	0.17	0.3	-0.48	0.31	0.6	-0.01	-0.41	0.51	-0.17	-0.77	0.01	-0.58	0.61	0.43		-0.68	1.0	-0.4
Intangible Assets	-0.04	0.73	0.51	0.23	-0.23	0.91	0.38	-0.75	-0.23	0.04	0.82	-0.14	-0.26	0.57	0.8	-0.05	0.2	0.9	0.38	0.87	-0.17	0.03	-0.68		-0.68	0.78
Common Stock Total Equity	0.53	-0.44	-0.34	-0.24	0.61	-0.65	-0.57	0.29	0.16	0.29	-0.49	0.31	0.6	-0.03	-0.42	0.51	-0.18	-0.78	0.0	-0.59	0.6	0.43	1.0	-0.68		-0.4
Other Assets	-0.05	0.35	0.56	0.07	-0.09	0.79	0.33	-0.68	-0.19	-0.12	0.89	0.05	-0.32	0.8	0.89	0.16	-0.04	0.71	0.07	0.82	-0.18	-0.09	-0.4	0.78	-0.4

Click cells to compare fundamentals

Rockwell Medical Account Relationship Matchups

Rockwell Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	44.3M	77.7M	48.6M	46.6M	52.2M	37.3M
Other Current Liab	4.8M	5.3M	5.2M	7.8M	9.9M	10.4M
Total Current Liabilities	12.4M	12.8M	21.0M	17.7M	16.6M	9.7M
Total Stockholder Equity	20.3M	34.2M	2.5M	14.1M	21.3M	19.2M
Property Plant And Equipment Net	5.6M	5.6M	10.2M	8.6M	11.0M	11.6M
Net Debt	(7.8M)	(24.7M)	15.6M	(5.1M)	4.5M	4.7M
Retained Earnings	(306.5M)	(337.4M)	(370.1M)	(388.8M)	(397.2M)	(377.3M)
Accounts Payable	3.0M	4.2M	3.7M	4.1M	4.5M	4.1M
Cash	11.8M	48.7M	13.3M	21.5M	9.0M	13.5M
Non Current Assets Total	7.4M	8.3M	13.3M	11.3M	23.4M	24.6M
Non Currrent Assets Other	875.9K	1.8M	2.1M	1.8M	705K	1.1M
Cash And Short Term Investments	26.0M	58.7M	22.4M	21.5M	10.9M	10.4M
Net Receivables	4.2M	4.2M	5.9M	6.3M	10.9M	11.4M
Common Stock Shares Outstanding	5.5M	6.9M	8.5M	9.9M	23.3M	24.5M
Liabilities And Stockholders Equity	44.3M	77.7M	48.6M	46.6M	52.2M	37.3M
Inventory	3.6M	3.9M	4.1M	5.8M	5.9M	3.8M
Other Current Assets	3.0M	2.7M	2.9M	1.7M	1.1M	1.1M
Other Stockholder Equity	326.8M	371.5M	372.6M	402.7M	418.5M	439.4M
Total Liab	24.0M	43.6M	46.0M	32.5M	30.9M	18.1M
Property Plant And Equipment Gross	5.6M	2.6M	17.3M	16.2M	19.8M	20.8M
Total Current Assets	36.9M	69.5M	35.3M	35.3M	28.8M	31.1M
Accumulated Other Comprehensive Income	52.0K	57K	52K	163K	(1K)	(1.1K)
Short Term Debt	2.3M	1.2M	9.8M	4.1M	2.2M	1.8M
Common Stock	299.6M	6.5K	9K	1K	3K	2.9K
Intangible Assets	4.0K	3.7K	3.3K	10.8M	12.4M	13.0M
Common Stock Total Equity	273.2M	299.6M	6.5K	9K	10.4K	9.8K
Other Assets	875.9K	4.7M	2.1M	13.8M	15.9M	16.7M
Short Term Investments	14.3M	10.0M	9.2M	11.4M	2.0M	1.9M
Non Current Liabilities Total	11.6M	30.8M	25.1M	14.8M	14.2M	9.8M
Property Plant Equipment	2.9M	5.6M	10.2M	8.6M	9.9M	10.4M
Current Deferred Revenue	2.3M	2.3M	2.3M	1.8M	46K	43.7K
Net Tangible Assets	19.4M	33.2M	1.6M	13.2M	11.9M	20.7M
Retained Earnings Total Equity	(240.3M)	(272.4M)	(306.5M)	(337.4M)	(303.7M)	(318.8M)
Other Liab	9.8M	8.0M	6M	2.6M	2.4M	2.2M

Currently Active Assets on Macroaxis

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America
S	SentinelOne
WD	Walker Dunlop

When determining whether Rockwell Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Rockwell Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Rockwell Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Rockwell Medical Stock:

How To Invest In Rockwell

Details

Is Rockwell Stock a good investment?

Details

What is Rockwell Medical's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Drug Manufacturers - Specialty & Generic Companies

View

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rockwell Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more detail on how to invest in Rockwell Stock please use our How to Invest in Rockwell Medical guide.

You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rockwell Medical. If investors know Rockwell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rockwell Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.04)

Revenue Per Share

3.041

Quarterly Revenue Growth

0.429

Return On Assets

(0.04)

Return On Equity

(0.29)

The market value of Rockwell Medical is measured differently than its book value, which is the value of Rockwell that is recorded on the company's balance sheet. Investors also form their own opinion of Rockwell Medical's value that differs from its market value or its book value, called intrinsic value, which is Rockwell Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rockwell Medical's market value can be influenced by many factors that don't directly affect Rockwell Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Rockwell Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Rockwell Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rockwell Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Rockwell Net Debt vs Deferred Long Term Liab Analysis

Net Debt vs Deferred Long Term Liab

Net Debt vs Deferred Long Term Liab Correlation Analysis

Correlation Coefficient

Net Debt

Deferred Long Term Liab

Rockwell Medical fundamental ratios Correlations

Rockwell Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Rockwell Medical fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Common Stock Total Equity	+ 1.0	Common Stock
Total Current Assets	+ 0.98	Total Assets
Total Current Assets	+ 0.98	Cash And Short Term Investments
Property Plant And Equipment Gross	+ 0.97	Property Plant And Equipment Net
Common Stock Shares Outstanding	+ 0.96	Non Current Assets Total
Cash And Short Term Investments	+ 0.94	Total Assets

Cash And Short Term Investments	- 0.85	Net Debt
Cash	- 0.85	Net Debt
Retained Earnings	- 0.84	Property Plant And Equipment Net
Net Debt	- 0.82	Total Stockholder Equity
Other Stockholder Equity	- 0.81	Retained Earnings
Total Current Assets	- 0.79	Net Debt